Skip to main navigation

Corporate
Healthcare Professionals
Patients

Health Policy Resources
Contact Us

About Axonics
- Who We Are
- Leadership
Investor Relations
Careers
Contact Us

News Releases

News Releases

Year

Apr 15, 2021

Axonics® to Report First Quarter 2021 Financial Results on May 6, 2021

Mar 03, 2021

Axonics® to Participate in the Barclays Global Healthcare Conference

Mar 02, 2021

Axonics® Announces Strategic Alliance for the Manufacture of New Non-Rechargeable Implantable Sacral Neuromodulation Device

Feb 25, 2021

Axonics® Reports Fourth Quarter and Fiscal Year 2020 Results

Feb 25, 2021

Axonics® Expands into Stress Urinary Incontinence with the Acquisition of Bulkamid®

Feb 22, 2021

Axonics® to Report Fourth Quarter and Fiscal Year 2020 Financial Results on February 25, 2021

Feb 18, 2021

Axonics® to Participate in the Society for Urodynamics, Female Pelvic Medicine & Urogenital Reconstruction 2021 Winter Meeting

Feb 16, 2021

Axonics® Receives FDA Approval for Third-Generation Implantable Neurostimulator

Feb 11, 2021

Axonics® to Participate in the SVB Leerink Global Healthcare Conference

Jan 25, 2021

Axonics® Reports Preliminary Fourth Quarter and Fiscal Year 2020 Revenue

Print Page Email Page Email Alerts RSS Feeds

Questions?

We are here to help answer any questions you may have about the Axonics System and Therapy.

CONTACT US

Corporate Healthcare Professionals Patients

About Axonics Investor Relations Careers Contact Us

Contact Us

©2021 Axonics, Inc. Axonics^® is a trademark of Axonics, Inc., registered or pending registration in the U.S. and other countries.
Privacy Policy | Terms of Use | Important Safety Information | Sitemap